Medical Writing Trends in medical writing Lay summaries and writing for patients: Where are we now and where are we going?
front-coverpng

Volume 28, Issue 3 - Trends in medical writing

Lay summaries and writing for patients: Where are we now and where are we going?

Abstract

We examine the trend for increasing and more transparent patient information and ask how close we have come in the last few years to producing useful and meaningful information for patients. We also outline the challenges faced by medical writers and the pharmaceutical industry as a whole in trying to comply with recent European require - ments for the creation of lay summaries of key regulatory submission documents. The risk management plan and the results section describe outcomes of clinical trials – and what this means for patients – who are the target audience that this monumental effort is intended to help.

Download the full article

References

  1. Pires C, Vigário M, Cavaco A. Readability of medicinal package leaflets: a systematic review. Rev Saude Publica. 2015;49:4.
  2. Piñero-López MÁ, Modamio P, Lastra CF, Mariño EL. Readability analysis of the package leaflets for biological medicines available on the internet between 2007 and 2013: An analytical longitudinal study. J Med Internet Res. 2016 May 25;18(5):e100.
  3. Piñero-López MÁ, Figueiredo-Escribá C, Modamio P, Lastra CF, Mariño EL. Readability assessment of package leaflets of biosimilars. BMJ Open. 2019;9(1): e024837.
  4. Chamberlain James L, Creuwels LAJM, Davies M. Risk management plans – new challenges for a new era. Reg Rapp 2014; 11(6):4–7.
  5. Prechtel K, Rechtsteiner S. Medical writing for two audiences – The RMP public summary. Med Writ 2015;24(4):200–4.
  6. Guideline on good pharmacovigilance practices (GVP) Module V – Risk management systems (Rev 2) 28 March 2017 EMA/838713/2011 Rev 2*.
  7. Adult literacy [cited 2019 May 16]. Available from: https://literacytrust.org. uk/parents-and-families/adult-literacy/.
  8. Why reading age is a key factor in successful eLearning design [cited 2019 May 16] Available from: http://www.aurionlearning.com/onlinetraining- and-development-blog/2018/ june/why-reading-age-is-a-key-factor-insuccessful- elearning-design.
  9. European Medicines Agency (EMA). Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. UK: EMA. 2014 [cited 2018 March 12]. Available from: https://ec.europa.eu/health/sites/health/ files/files/eudralex/vol-1/reg_2014_536/ reg_2014_536_en. pdf.
  10. European Medicines Agency (EMA). Summaries of clinical trial results for laypersons. UK: EMA. 2018 [cited 2018 Mar 12]. Available from: https://ec.europa.eu/health/sites/health/ files/files/eudralex/vol-10/2017_01_26_ summaries_of_ct_results_for_laypersons. pdf.
  11. Thomas KB. Clinical trial disclosure and transparency: Regulation EU No. 536/2014 Public disclosure at the clinical trial level. Med Writ. 2018;27(2):7–17.
  12. Sroka-Saidi K, Boggetti B, Schindler TM. Transferring regulation into practice: The challenges of the new layperson summary of clinical trial results. Med Writ. 2015;24(1):24–7.
  13. Study results - lay summaries [cited 2019 May 16]. Available from: https://www.ucb.com/our-science/ Our-clinical-studies/Study-Results-Lay- Summaries.
  14. Lay summaries and lay summary videos [cited 2019 May 6]. Available from: https://trials.boehringer-ingelheim. com/trial_results/clinical_trials_overview /clinical_trial_result.c=n.i=.html? document_type=2.
  15. The Centre for Information and Study on Clinical Research Participation. Public and Patient Perceptions and Insights Study. Boston: CISCRP. [cited 2018 Mar 12]. Available from: https://www.ciscrp.org/ services/research-services/public-andpatient- perceptions-insights-study/.
  16. Summaries of clinical trial results for laypersons [cited 2019 May 28]. Available from: https://ec.europa.eu/health/sites/ health/files/files/eudralex/vol-10/ 2017_01_26_summaries_of_ct_ results_for_laypersons.pdf.
  17. Buljan I, Malički M, Wager E, Puljak L, Hren D, Kellie F, et al. No difference in knowledge obtained from infographic or plain language summary of a Cochrane systematic review: three randomized controlled trials. J Clin Epidemiol. 2017;pii:S0895–4356(17)30490–0.
  18. Say RE, Thomson R. The importance of patient preferences in treatment decisions - challenges for doctors. BMJ. 2003;327(7414):542–5.
  19. Patients’ preferences matter. Stop the silent misdiagnosis [cited May 2019 May 18]. Available from: https://www.kingsfund. org.uk/sites/default/files/field/field_ publication_file/patients-preferencesmatter- may-2012.pdf.
  20. Shared decision making [cited 2019 May 18]. Available from: https://www.england. nhs.uk/shared-decision-making/.
  21. MRCT Tool kit [cited 2019 May 18]. Available from: https://mrctcenter.org/ wp-content/uploads/2017/12/2017-12- 07-MRCT-Return-of-Aggregate-Results- Toolkit-3.1.pdf.
  22. Clinical trial results summary for laypersons: A user testing study [cited 2019 May 18]. Available from: http://luto.co.uk/ news/clinical-trial-results-summary-forlaypersons- a-user-testing-study/.
  23. Ipsen commits to making all its published scientific research freely accessible to everyone [cited 2019 May 28]. Available from: https://www.ipsen.com/ipsencommits- to-making-all-its-publishedscientific- research-freely-accessible-to-ever yone/.
  24. Shire Continues to Uphold High Standards of Ethics and Transparency with Adoption of Open Access Policy for Publication of Shire-Supported Research [cited May 2019 May 18]. Available from: https://www.shire.com/en/newsroom/ 2018/january/xajhds.
  25. Layperson Summaries of Clinical Trials: An Implementation Guide [cited 2019 May 18]. Available from: http://www.transceleratebiopharmainc. com/wp-content/uploads/2017/02/ Implementation-Recommendations_ 20Jan17_Final.docx.
  26. Roadmap Initiative to Good Lay Summary Practices Meeting [cited 2019 May 25]. Available from: https://www.eupati.eu/ blog/roadmap-initiative-to-good-laysummary- practices-meeting/.
  27. Guide to appraising health information [cited 2019 May 25]. Available from: https://www.pifonline.org.uk/wpcontent/ uploads/2014/11/PIF-Guide- Appraising-Health-Information-2010.pdf.
  28. Barnfield S, Pitts AC, Kalaria R, Allan L, Tullo E. “Is all the stuff about neurons necessary?” The development of lay summaries to disseminate findings from the Newcastle Cognitive Function after Stroke (COGFAST) study. Res Involv Engagem. 2017;3:18.
  29. Plain Language Summaries (PLS) of Publications Toolkit [cited 2019 May 18]. Available from: https://www.envisionthepatient.com/ plstoolkit/.
  30. The Social Life of Health Information [cited 2019 May 28]. Available from: https://www.pewinternet.org/wpcontent/ uploads/sites/9/media/Files/ Reports/2009/PIP_Health_2009.pdf.
  31. Do patients search for online health information? [cited 2019 May 16]. Available from: https://trialfacts.com/ do-patients-search-for-online-healthinformation/.

Search

Articles

Introduction
President's Message
EMWA News
Omics in silico and other trends in biomedical research: Impact on how and what we write
Catching the wave of lifestyle medicine
Artificial intelligence – will we be replaced by robots?
Now more than ever, scientists must speak up for science
When less is more: Medical writers as guardians of curated content
Predatory publishing – what medical communicators need to know
AMWA – EMWA – ISMPP Joint Position Statement on Predatory Publishing
How to combat medical misinformation with a sound content strategy
Subcontracting: Not for the faint of heart
Lay summaries and writing for patients: Where are we now and where are we going?
Clinical trial disclosure: Perspective from a medical writer for a contract research organisation
The 360° approach to authoring risk management plans
Trends in regulatory writing: A brief overview for aspiring medical writers
The medical writing landscape in China
News from the EMA
Regulatory Matters
Medical Communications and Writing for Patients
In the Bookstores
Getting Your Foot in the Door
Veterinary Medical Writing
Medical Devices
My First Medical Writing
Journal Watch
Good Writing Practice
Regulatory Public Disclosure
Out on Our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: